XML 168 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities      
Net loss from continuing operations $ (33,937,956) $ (28,452,232) $ (34,080,963)
Add (deduct) items not affecting cash      
Depreciation and amortization 4,045,523 3,900,458 1,943,048
Impairment of right-of-use asset 0 89,860 183,161
Interest expense 69,404 7,860 155,315
Share-based payments 7,443,930 8,052,011 12,082,930
Change in fair value of other investments 858,483 770,874 8,778,707
Change in fair value of derivative liability (682,507) (2,561,456) 2,684,436
Unrealized foreign exchange gain (loss) 0 (327,161) 0
Loss (gain) on settlement of financial liability (49,792) (680,164) 18,665
Changes in non-cash working capital balances      
Other receivables (106,880) 435,183 (387,837)
Prepaid expenses and deposits (609,153) (526,738) (24,214)
Trade and other payables 3,604,766 898,691 1,516,025
Cash used in continuing operating activities (19,364,182) (18,392,814) (7,130,727)
Cash used in discontinued operating activities (1,382,041) (737,659) (6,581,998)
Cash used in operating activities (20,746,223) (19,130,473) (13,712,725)
Investing activities      
Cash acquired from acquisition of Prismic Pharmaceuticals Inc. 0 0 1,752
Cash acquired from acquisition of Lucid Psycheceuticals Inc. 768,964 0 0
Additions to intangible assets (500,000) 0 (293,126)
Proceeds from sale of investments 0 6,477,510 462,303
Cash provided by continuing investing activities 268,964 6,477,510 170,929
Cash provided by (used in) discontinued investing activities 0 36,616 (401,817)
Cash provided by (used in) investing activities 268,964 6,514,126 (230,888)
Financing activities      
Proceeds from issuance of shares, net 38,341,407 25,100,459 3,431,294
Proceeds from exercise of share-options 0 59,548 551,133
Proceeds from exercise of warrants 0 0 71,461
Repayment of notes payable (71,759) (946,643) 0
Repayment of lease obligation (57,566) (39,993) (42,285)
Cash provided by continuing financing activities 38,212,082 24,173,371 4,011,603
Cash provided by discontinued financing activities 0 0 0
Cash provided by financing activities 38,212,082 24,173,371 4,011,603
Net increase (decrease) 17,734,823 11,557,024 (9,932,010)
Cash, beginning of the year 17,524,822 5,967,798 15,899,808
Cash, end of the year $ 35,259,645 $ 17,524,822 $ 5,967,798